ACOR logo

Acorda Therapeutics (ACOR) Depreciation And Amortization

Annual D&A

$31.67 M
-$1.14 M-3.48%

December 31, 2023

Summary

Performance

1-Year Change

-3.48%

3-Year Change

-23.32%

5-Year Change

+175.86%

15-Year Change

+36.29%

ACOR Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$41.30 M
ACOR annual depreciation & amortization is currently -23.32% below its historical high of $41.30 million

3-Year Low

$31.67 M
ACOR annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ACOR previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ACOR next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$140.90 M
ACOR annual total expenses is $140.90 million

Annual Operating Expenses

$125.61 M
ACOR annual total operating expenses is $125.61 million

Annual Cost Of Goods Sold

$15.28 M
ACOR annual cost of goods sold is $15.28 million

Annual Interest Expense

$31.53 M
ACOR annual interest expense is $31.53 million

Quarterly D&A

$882.00 K
-$7.04 M-88.87%

March 31, 2024

Summary

Performance

3-Month Change

-88.87%

1-Year Change

-88.85%

3-Year Change

-89.66%

5-Year Change

-81.81%

ACOR Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$10.60 M
ACOR quarterly depreciation & amortization is currently -91.68% below its historical high of $10.60 million

3-Year Low

$882.00 K
ACOR quarterly depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
ACOR previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
ACOR next earnings announcement has not yet been scheduled

Related metrics

Quarterly Total Expenses

$33.68 M
ACOR quarterly total expenses is $33.68 million

Quarterly Operating Expenses

$29.97 M
ACOR quarterly total operating expenses is $29.97 million

Quarterly Cost Of Goods Sold

$3.71 M
ACOR quarterly cost of goods sold is $3.71 million

Quarterly Interest Expense

$8.06 M
ACOR quarterly interest expense is $8.06 million

TTM D&A

$24.64 M
-$7.03 M-22.20%

March 31, 2024

Summary

Performance

3-Month Change

-22.2%

1-Year Change

-23.47%

3-Year Change

-38.02%

5-Year Change

-28.74%

ACOR TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$41.30 M
ACOR TTM depreciation & amortization is currently -40.35% below its historical high of $41.30 million

3-Year Low

$24.64 M
ACOR TTM depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2024
ACOR previous earnings announcement was published on Mar 31, 2024

Next Quarterly Earnings Report Date

N/A
ACOR next earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$140.90 M
ACOR annual total expenses is $140.90 million

Annual Operating Expenses

$125.61 M
ACOR annual total operating expenses is $125.61 million

TTM Cost Of Goods Sold

$15.76 M
ACOR TTM cost of goods sold is $15.76 million

TTM Interest Expense

$32.67 M
ACOR TTM interest expense is $32.67 million

ACOR Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-3.5%-88.8%-23.5%
3 y3 years-23.3%-89.7%-38.0%
5 y5 years+175.9%-81.8%-28.7%

ACOR Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-6.7%at low-89.7%at low-27.5%at low
5 y5-year-23.3%at low-91.7%at low-40.3%at low
alltimeall time-23.3%-102.3%-91.7%-407.5%-40.3%-102.7%

Acorda Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Mar 2024
-
$882.00 K(-88.9%)
$24.64 M(-22.2%)
Dec 2023
$31.67 M(-3.5%)
$7.92 M(+0.1%)
$31.67 M(-0.4%)
Sep 2023
-
$7.92 M(+0.1%)
$31.78 M(+0.4%)
Jun 2023
-
$7.91 M(0.0%)
$31.66 M(-1.6%)
Mar 2023
-
$7.91 M(-1.6%)
$32.19 M(-1.9%)
Dec 2022
$32.81 M(-3.4%)
$8.04 M(+3.1%)
$32.81 M(-1.3%)
Sep 2022
-
$7.79 M(-7.7%)
$33.24 M(-1.6%)
Jun 2022
-
$8.44 M(-1.1%)
$33.77 M(-0.6%)
Mar 2022
-
$8.53 M(+0.7%)
$33.96 M(+0.0%)
Dec 2021
$33.95 M(-17.8%)
$8.47 M(+1.8%)
$33.95 M(-5.3%)
Sep 2021
-
$8.32 M(-3.6%)
$35.86 M(-5.1%)
Jun 2021
-
$8.63 M(+1.3%)
$37.78 M(-4.9%)
Mar 2021
-
$8.53 M(-17.8%)
$39.75 M(-3.8%)
Dec 2020
$41.30 M(+19.5%)
$10.38 M(+1.3%)
$41.30 M(+1.2%)
Sep 2020
-
$10.24 M(-3.3%)
$40.80 M(+1.1%)
Jun 2020
-
$10.60 M(+5.2%)
$40.37 M(+1.4%)
Mar 2020
-
$10.08 M(+2.0%)
$39.80 M(+15.1%)
Dec 2019
$34.57 M(+201.2%)
$9.88 M(+0.6%)
$34.57 M(+27.8%)
Sep 2019
-
$9.82 M(-2.1%)
$27.06 M(+37.3%)
Jun 2019
-
$10.03 M(+106.8%)
$19.71 M(+51.4%)
Mar 2019
-
$4.85 M(+105.4%)
$13.02 M(+13.4%)
Dec 2018
$11.48 M(-50.6%)
$2.36 M(-4.4%)
$11.48 M(-22.8%)
Sep 2018
-
$2.47 M(-26.0%)
$14.87 M(-18.1%)
Jun 2018
-
$3.34 M(+0.8%)
$18.16 M(-13.1%)
Mar 2018
-
$3.31 M(-42.4%)
$20.90 M(-10.1%)
Dec 2017
$23.23 M(+7.7%)
$5.75 M(-0.2%)
$23.23 M(-0.2%)
Sep 2017
-
$5.76 M(-5.2%)
$23.29 M(-0.4%)
Jun 2017
-
$6.08 M(+7.6%)
$23.39 M(+0.5%)
Mar 2017
-
$5.65 M(-2.8%)
$23.28 M(+7.9%)
Dec 2016
$21.58 M(+43.8%)
$5.81 M(-0.9%)
$21.58 M(+9.9%)
Sep 2016
-
$5.86 M(-1.8%)
$19.63 M(+12.6%)
Jun 2016
-
$5.97 M(+51.1%)
$17.44 M(+14.3%)
Mar 2016
-
$3.95 M(+2.3%)
$15.25 M(+1.6%)
Dec 2015
$15.01 M(+77.2%)
$3.86 M(+5.4%)
$15.01 M(+5.3%)
Sep 2015
-
$3.66 M(-3.2%)
$14.25 M(+15.5%)
Jun 2015
-
$3.78 M(+2.1%)
$12.34 M(+18.4%)
Mar 2015
-
$3.71 M(+19.7%)
$10.42 M(+23.0%)
Dec 2014
$8.47 M
$3.10 M(+76.9%)
$8.47 M(+9.3%)
DateAnnualQuarterlyTTM
Sep 2014
-
$1.75 M(-6.1%)
$7.75 M(+0.5%)
Jun 2014
-
$1.86 M(+6.0%)
$7.71 M(+4.8%)
Mar 2014
-
$1.76 M(-26.0%)
$7.36 M(+5.1%)
Dec 2013
$7.00 M(+50.1%)
$2.38 M(+38.9%)
$7.00 M(+12.2%)
Sep 2013
-
$1.71 M(+13.2%)
$6.24 M(+10.9%)
Jun 2013
-
$1.51 M(+8.0%)
$5.62 M(+9.2%)
Mar 2013
-
$1.40 M(-13.2%)
$5.15 M(+10.5%)
Dec 2012
$4.66 M(+0.8%)
$1.61 M(+46.9%)
$4.66 M(+4.4%)
Sep 2012
-
$1.10 M(+5.6%)
$4.47 M(+1.5%)
Jun 2012
-
$1.04 M(+14.0%)
$4.40 M(+0.1%)
Mar 2012
-
$912.00 K(-35.6%)
$4.40 M(-4.9%)
Dec 2011
$4.63 M(+17.1%)
$1.42 M(+37.2%)
$4.63 M(+6.5%)
Sep 2011
-
$1.03 M(-0.3%)
$4.34 M(-0.1%)
Jun 2011
-
$1.04 M(-9.0%)
$4.34 M(+2.2%)
Mar 2011
-
$1.14 M(+0.5%)
$4.25 M(+7.6%)
Dec 2010
$3.95 M(+43.1%)
$1.13 M(+9.3%)
$3.95 M(+3645.0%)
Sep 2010
-
$1.04 M(+10.0%)
$105.50 K(-96.6%)
Jun 2010
-
$943.00 K(+12.5%)
$3.14 M(+23.1%)
Mar 2010
-
$838.00 K(-130.9%)
$2.55 M(-7.5%)
Dec 2009
$2.76 M(+674.2%)
-$2.71 M(-166.6%)
$2.76 M(-51.3%)
Sep 2009
-
$4.08 M(+1054.9%)
$5.67 M(+8071.0%)
Jun 2009
-
$352.90 K(-66.2%)
$69.40 K(-94.3%)
Mar 2009
-
$1.05 M(+431.8%)
$1.23 M(+243.9%)
Dec 2008
$356.70 K(-154.5%)
$196.60 K(-112.9%)
$356.80 K(-460.4%)
Sep 2008
-
-$1.53 M(-201.0%)
-$99.00 K(-110.5%)
Jun 2008
-
$1.51 M(+762.3%)
$941.90 K(-294.8%)
Mar 2008
-
$175.20 K(-167.6%)
-$483.40 K(-26.2%)
Dec 2007
-$655.00 K(-141.4%)
-$259.20 K(-46.5%)
-$655.00 K(+525.6%)
Sep 2007
-
-$484.80 K(-667.7%)
-$104.70 K(-113.3%)
Jun 2007
-
$85.40 K(+2272.2%)
$785.70 K(-31.5%)
Mar 2007
-
$3600.00(-98.8%)
$1.15 M(-27.5%)
Dec 2006
$1.58 M(-12.7%)
$291.10 K(-28.2%)
$1.58 M(+22.5%)
Sep 2006
-
$405.60 K(-9.1%)
$1.29 M(+45.8%)
Jun 2006
-
$446.40 K(+1.6%)
$885.90 K(+101.6%)
Mar 2006
-
$439.50 K(-324.7%)
$439.50 K(-324.7%)
Dec 2005
$1.81 M(-41.0%)
-
-
Dec 2004
$3.07 M(-514.7%)
-
-
Sep 2003
-
-$195.60 K
-$195.60 K
Jun 2003
-$740.20 K
-
-

FAQ

  • What is Acorda Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Acorda Therapeutics?
  • What is Acorda Therapeutics annual D&A year-on-year change?
  • What is Acorda Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Acorda Therapeutics?
  • What is Acorda Therapeutics quarterly D&A year-on-year change?
  • What is Acorda Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Acorda Therapeutics?
  • What is Acorda Therapeutics TTM D&A year-on-year change?

What is Acorda Therapeutics annual depreciation & amortization?

The current annual D&A of ACOR is $31.67 M

What is the all time high annual D&A for Acorda Therapeutics?

Acorda Therapeutics all-time high annual depreciation & amortization is $41.30 M

What is Acorda Therapeutics annual D&A year-on-year change?

Over the past year, ACOR annual depreciation & amortization has changed by -$1.14 M (-3.48%)

What is Acorda Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of ACOR is $882.00 K

What is the all time high quarterly D&A for Acorda Therapeutics?

Acorda Therapeutics all-time high quarterly depreciation & amortization is $10.60 M

What is Acorda Therapeutics quarterly D&A year-on-year change?

Over the past year, ACOR quarterly depreciation & amortization has changed by -$7.03 M (-88.85%)

What is Acorda Therapeutics TTM depreciation & amortization?

The current TTM D&A of ACOR is $24.64 M

What is the all time high TTM D&A for Acorda Therapeutics?

Acorda Therapeutics all-time high TTM depreciation & amortization is $41.30 M

What is Acorda Therapeutics TTM D&A year-on-year change?

Over the past year, ACOR TTM depreciation & amortization has changed by -$7.55 M (-23.47%)